1. Bakker, Mark K, van Straten, Tijmen, Chong, Michael, Gill, Dipender, Ruigrok, Ynte M. 2022. Anti-Epileptic Drug Target Perturbation and Intracranial Aneurysm Risk: Mendelian Randomization and Colocalization Study. In Stroke, 54, 208-216. doi:10.1161/STROKEAHA.122.040598. https://pubmed.ncbi.nlm.nih.gov/36300369/
2. Zhou, Dan-Yang, Su, Xi, Wu, Yong, Li, Ming, Song, Meng. 2023. Decreased CNNM2 expression in prefrontal cortex affects sensorimotor gating function, cognition, dendritic spine morphogenesis and risk of schizophrenia. In Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 49, 433-442. doi:10.1038/s41386-023-01732-y. https://pubmed.ncbi.nlm.nih.gov/37715107/
3. García-Castaño, Alejandro, Madariaga, Leire, Antón-Gamero, Montserrat, Castaño, Luis, Gaztambide, Sonia. 2020. Novel variant in the CNNM2 gene associated with dominant hypomagnesemia. In PloS one, 15, e0239965. doi:10.1371/journal.pone.0239965. https://pubmed.ncbi.nlm.nih.gov/32997713/
4. Wu, Congyan, Liu, Hanchen, Zuo, Qiao, Zhao, Rui, Liu, Jianmin. . Identifying novel risk genes in intracranial aneurysm by integrating human proteomes and genetics. In Brain : a journal of neurology, 147, 2817-2825. doi:10.1093/brain/awae111. https://pubmed.ncbi.nlm.nih.gov/39084678/
5. Liu, Xianxia, Chen, Lei, Zhang, Yuansheng, Wu, Cengfan, Chen, Yuewu. 2018. Associations between polymorphisms of the CXCL12 and CNNM2 gene and hypertension risk: A case-control study. In Gene, 675, 185-190. doi:10.1016/j.gene.2018.06.107. https://pubmed.ncbi.nlm.nih.gov/30180964/
智鼠故事 
